IL38546A0 - A process for the preparation of new complexes of biologically active peptides,polypeptides,proteins or derivatives or salts thereof having prolonged and/or increased activity - Google Patents

A process for the preparation of new complexes of biologically active peptides,polypeptides,proteins or derivatives or salts thereof having prolonged and/or increased activity

Info

Publication number
IL38546A0
IL38546A0 IL38546A IL3854672A IL38546A0 IL 38546 A0 IL38546 A0 IL 38546A0 IL 38546 A IL38546 A IL 38546A IL 3854672 A IL3854672 A IL 3854672A IL 38546 A0 IL38546 A0 IL 38546A0
Authority
IL
Israel
Prior art keywords
polypeptides
prolonged
proteins
derivatives
salts
Prior art date
Application number
IL38546A
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of IL38546A0 publication Critical patent/IL38546A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/14—Enzymes or microbial cells immobilised on or in an inorganic carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/085—Angiotensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A61K38/35—Corticotropin [ACTH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
IL38546A 1971-01-20 1972-01-12 A process for the preparation of new complexes of biologically active peptides,polypeptides,proteins or derivatives or salts thereof having prolonged and/or increased activity IL38546A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HURI000418 1971-01-20

Publications (1)

Publication Number Publication Date
IL38546A0 true IL38546A0 (en) 1972-03-28

Family

ID=11000857

Family Applications (1)

Application Number Title Priority Date Filing Date
IL38546A IL38546A0 (en) 1971-01-20 1972-01-12 A process for the preparation of new complexes of biologically active peptides,polypeptides,proteins or derivatives or salts thereof having prolonged and/or increased activity

Country Status (10)

Country Link
AU (1) AU3784072A (en)
BE (1) BE778239A (en)
CA (1) CA972288A (en)
DD (1) DD98915A5 (en)
DE (1) DE2202176A1 (en)
ES (1) ES399033A1 (en)
FR (1) FR2122529A1 (en)
IL (1) IL38546A0 (en)
NL (1) NL7200716A (en)
ZA (1) ZA72252B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS563846B2 (en) * 1972-10-12 1981-01-27
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
DE3230736A1 (en) * 1982-08-18 1984-02-23 Herbert Prof. Dr. 8400 Regensburg Rupprecht ACTIVE SUBSTANCES BONDED TO SILICON DIOXIDE, METHOD FOR THEIR PRODUCTION AND THEIR USE
DE3502099A1 (en) * 1985-01-23 1986-08-07 Dieter Prof. Dr. Dr. 5883 Kierspe Aderhold THERAPEUTIC, PEPTIDE AND / OR AMINO ACID CONTAINER
US5130298A (en) * 1989-05-16 1992-07-14 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
FR2799758B1 (en) 1999-10-15 2002-05-17 Exsymol Sa COMPLEX BASED ON BIOLOGICALLY ASSIMILABLE ORTHOSILICIC ACID, IN SOLID, STABLE AND CONCENTRATED FORM, AND PREPARATION METHOD

Also Published As

Publication number Publication date
NL7200716A (en) 1972-07-24
DE2202176A1 (en) 1972-08-03
DD98915A5 (en) 1973-07-12
ES399033A1 (en) 1975-05-16
AU3784072A (en) 1973-07-19
BE778239A (en) 1972-05-16
CA972288A (en) 1975-08-05
FR2122529A1 (en) 1972-09-01
FR2122529B1 (en) 1975-12-26
ZA72252B (en) 1972-09-27

Similar Documents

Publication Publication Date Title
HU172927B (en) Process for preparing azolyl-/1/-methanes, salts thereof and pharmaceutical preparations containing such active materials
SE415660B (en) PROCEDURE FOR PREPARING BIOLOGICALLY ACTIVE, PREPARED PROTEINS
EG11503A (en) New water-insoluble preparations of peptide materials,their production and their use
CA987231A (en) Biologically active material
AU462701B2 (en) Polymer biologically active protein complexes
IL38546A0 (en) A process for the preparation of new complexes of biologically active peptides,polypeptides,proteins or derivatives or salts thereof having prolonged and/or increased activity
NL179816C (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION WITH A BETA-BLOCKING ACTIVITY, PHARMACEUTICAL ARTICLES MANUFACTURED AND PROCESS FOR THE PREPARATION OF NEW 5- (2-HYDROXY-3-SUBSTRUCTIUS-PROBYSTHYL-PROSTURBED-AMINO-CARBO) SALTS THEREOF.
EP0018976A4 (en) Medical protein hydrolysate and process of using the same.
PH9660A (en) 17alpha,21-oxygenated-11beta-hydroxy-3,20-dioxo-d-homo-pregnanes and the pharmaceutical preparations containing them
EG11309A (en) A process for the preparation of biologically active polypeptides containing aspartyl group
IL41885A0 (en) New water-insoluble preparations of peptide materials,their production and their use
AU467984B2 (en) Biologically active two-component complexes
IL42973A0 (en) Peptides of acth activity containing alpha-aminooxy carboxylic acid on the n-terminal moiety,and a process for the preparation thereof
ZA744354B (en) Novel amino acids, and their production and use
ZA741015B (en) Pharmaceutically active new leurosine derivatives and a process for the preparation thereof
IL45779A (en) 1-oxo-2-aryl or thienyl-2-substituted-5-indanyloxy-alkanoic acids and derivatives thereof,processes for their preparation and pharmaceutical compositons containing them
IL43284A0 (en) New derivatives of 3-amino-5-sulfamoyl-benzoic acid,their manufacture and pharmaceutical preparations containing the
EG12098A (en) New pharmaceutical insulin preparations having antidiabetic activity and process for their manufacture
HU172245B (en) Process for preparing 1,4-dihydro-2h-isoquinoline derivatives and pharmaceutical preparations containing such active materials
GB1408108A (en) Pyrrolylacrylic acids with hypoglycemic activity 4,4-dinitrocarbanilide complexes their preparation and use
CA867355A (en) Process for the preparation of biologically active polypeptides
AU5033572A (en) Biologically active material
CA966830A (en) Biologically active substance
IL46090A0 (en) Cyclopenteno-quinolone derivatives,processes for the preparation thereof and pharmaceutical preparations containing same
ZA74837B (en) Biologically active substances, production and use thereof